The effect of ulcer healing with eradication of Helicobacter pylon (H pylon) on gastric function was investigated in nine patients with duodenal ulcer disease. One month after eradication there were significant reductions in both basal plasma gastrin concentration, from a median (range) of 19 (1-22) to 6 (2-15) pmol/l (p<0-05), and of basal acid secretion from (2.4-24) to 2-6 (1.4-8-1) mM H+/h, (p<0.01).
to 2-6 (1.4-8-1) mM H+/h, (p<0.01).
The peak acid secretion rate was unchanged from 37 to 37 (21-59) mM H+/h. After treatment there was no change in the parietal cell sensitivity to stepped infusions of gastrin heptadecapeptide: the median concentration of gastrin required for 50% of maximal acid secretion (ECso) was 41 (14.8-126) before and 33 pmol/l after eradication of H pylon. The metabolic clearance rate of gastrin was also unaffected by the eradication of H pylon. Thus eradication of H pylon infection from patients with active duodenal ulcers is accompanied by falls in both basal gastrin release and basal acid secretion without a change in the parietal cell sensitivity to gastrin. Cyclical changes in H pylon infection may cause the variations in basal acid secretion that are seen in duodenal ulcer disease.
Despite the strong epidemiological and clinical evidence implicating the bacterium Helicobacter pyloni (H pylon) in the pathogenesis of chronic duodenal ulcer disease,' the way that the organism promotes recurrence of ulcers remains unclear.
The discovery that H pylori increases plasma gastrin concentrations raised the possibility that H pyloni may be responsible for the known abnormalities of gastric acid secretion that have been described in patients with duodenal ulcers. These include high basal and peak acid outputs, a high ratio of basal to peak acid secretion, increased meal stimulated acid output, and impairment of the normal inhibition of gastrin release and acid secretion by luminal acid. 2 Patients attended the clinical investigation unit at 9 00 am after fasting overnight. Indwelling venous cannulae were inserted into the right forearm for infusion of G17 and into the left forearm for blood sampling. Gastric acid secretion was measured by aspiration as described by Baron.3 Briefly, a nasogastric tube was passed, resting juice was aspirated, and the position of the tube was checked by water recovery. The tube used was a multifenestrated sump tube with a second channel for infusing phenol red into the proximal stomach and a third lumen for equilibration of intragastic and atmospheric pressure. The patient remained semirecumbent throughout. Gastric contents were constantly aspirated under 20 mm Hg negative pressure (Air Shields, Hatboro, Pa, USA) and the patency of the tube was ensured by the manual insufflation of 20 ml air every five minutes.
The G17 (Gastrin I Human; Sigma, Poole, Dorset, UK) made up in 0-15M saline containing 1% albumin was infused continuously by an infusion pump (Vickers Medical, Basingstoke, Hants, UK) at doses of 0, 11, 33, 100, and 300 pmol/kg/h, each for a 30 minute period. The largest dose produces maximal stimulation of acid secretion.'417 Gastric acid was collected continuously on to ice and the acid output during each 15 minute period was measured by titration to pH 7 with 0 1M NaOH. The rate of acid secretion was calculated with correction for pyloric losses and duodenogastric reflux by phenol red recovery and sodium measurement respectively.3 Median (range) gastric juice recoveries were 90 (74-100)% before and 85 (78-100)% after treatment. Basal acid output per hour was calculated by doubling the acid output during the 30 minutes of infusion of saline only. Other acid outputs were calculated by multiplying the acid output during the second 15 minutes of each infusion period by four. Blood samples were taken at the end of each infusion period for gastrin assay. Figure 3 shows that for the nine patients as a group, there was a linear relation between the mean plasma gastrin during infusion of G17 plotted on a log scale and the mean acid output at each of the G17 doses. This relation was linear both before and after treatment, with correlation coefficients of0-99 (p<0 001, 95% CI 0-89-1-00) and 0-98 (p<0 005, 95% CI 0-71-1-00) respectively. The only differences between the two lines is that after treatment there was a lower mean plasma gastrin concentration and a lower mean acid secretion rate under basal conditions. Consequently, the mean concentration of gastrin necessary to produce half maximal acid secretion (EC50) was identical, both before and after eradication ofH pylori.
Individual dose-response curves for each patient were also plotted. From these the EC50 for each patient -rather than the group as a whole -was determined, both before and after eradication of H pylori. In the nine patients in whom H pylori was eradicated, the median correlation coefficient of the individual regression plot of log dose against response was 0 93 (0 85-0 96) before and 0 94 (0 89-0-99) after treatment. There was no significant difference in the EC50 after the eradication of H pylori. The median EC50 was 41 (14-8-126 ) pmol/l before and 33 (23- 
to be significantly greater in patients with duodenal ulcers and with H pylori than in patients with duodenal ulcers without this infection.6 It is difficult to deduce the physiological effect of H pyloni on basal secretion from this and other studies in which patients do not act as their own controls, because other differences between the groups might affect acid secretion. For example, H pylon is implicated in the pathogenesis of atrophic gastritis,3' which may have led to decreased acid secretion through loss of parietal cells in groups of chronically infected subjects in some studies. 32 The fall in basal acid secretion found may not necessarily be due to the eradication ofH pylori. Achord noted that the basal acid output decreased after healing of an ulcer by drugs that do not eradicate H pylon,33 implying that the ulcer crater is itself associated with increased basal acid secretion. Further studies will be necessary to determine which factor -the ulcer crater or H pyloni -is reponsible for the increased basal acid output.
Our present findings are consistent with the generally accepted view that peak acid output reflects the parietal cell mass and is not altered by eradication of H pylori. 10 272930 The main purpose of our present study was to determine whether chronic infection with H pylori alters the sensitivity of the parietal cells to gastrin. This was suggested by the relative lack of change in rates of acid secretion and intragastric acidity on eradication ofH pyloni despite substantial falls in circulating gastrin concentrations,O'0 and by the suppression of acid secretion produced by H pylori on first infection. 34 We measured circulating gastrin to determine the concentrations ofgastrin required to produce half maximal acid secretion. There has been debate as to whether this should be calculated with or without subtraction of basal acid secretion. It is widely held that the increased basal acid secretion in patients with duodenal ulcer disease is determined by vagal drive rather than circulating gastrin.'02' This is the rationale for determining the basal subtracted EC50 in some previous studies.'314"79 We found that basalsubtracted EC50 does fall significantly on eradication of H pylorn, suggesting that the infection initially present did indeed decrease the sensitivity of parietal cells to gastrin. The effect of eradication of H pylori on basal gastrin and acid secretion is more consistent with the idea that circulating gastrin is responsible for driving basal acid secretion in patients with duodenal ulcer, because the fall in basal gastrin concentration on eradication was accompanied by a proportional fall in basal acid secretion. Therefore the EC50, rather than the derived basalsubtracted EC50, is likely to be the most appropriate measure of parietal cell sensitivity and the EC50 did not change after healing with eradication ofH pylori. It is now clear that the change in basal-subtracted EC50 on eradication plus healing is only a mathematical consequence of the fall in gastrin driven basal acid secretion. This is best appreciated when the mean acid output is plotted against mean plasma gastrin concentration for each G17 infusion (Fig 3) ; the two lines are identical when exogenous gastrin is infused. These graphs are similar to those obtained by 
